Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4812 Target Snapshot

Kallikrein-8 · SINGLE PROTEIN · Homo sapiens

40Compounds
12Assays
0Approved Drugs
31.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt O60259. Use UniProt O60259 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt O60259 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Kallikrein-8 as ChEMBL target CHEMBL4812, mapped to UniProt O60259. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Kallikrein-8
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL4812
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
O60259
Kallikrein-8
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Kallikrein-8 is the right protein anchor across sources, using UniProt O60259 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelKallikrein-8
UniProt AccessionO60259
Component TypeProtein
Sequence Length260 aa

Kallikrein-8

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Kallikrein-8, mapped to UniProt O60259. Sequence length is 260 aa.

Mapped IDO60259
Review nameKallikrein-8
OrganismHomo sapiens
Assay Mix

Activity Type Distribution

IC5031.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL4558285 8.2 IC50 6.31 Preclinical
CHEMBL4447752 7.6 IC50 25.12 Preclinical
CHEMBL4465265 7.5 IC50 31.62 Preclinical
CHEMBL4517343 7.0 IC50 100.0 Preclinical
CHEMBL239331 6.9 IC50 125.0 Preclinical
CHEMBL239535 6.77 IC50 170.0 Preclinical
CHEMBL3770794 6.77 IC50 170.0 Preclinical
CHEMBL4436048 6.7 IC50 199.53 Preclinical
CHEMBL4206734 6.68 IC50 210.0 Preclinical
CHEMBL4461533 6.6 IC50 251.19 Preclinical
Distribution

pChEMBL Value Distribution

4
5.0
4
5.5
3
6.0
8
6.5
1
7.0
2
7.5
1
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

12
Total Assays
24
Tested Compounds
2
Assay Types
Binding — 11 assays, 24 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 6 1 5.0
assay format 4 8 6.3
cell-based format 1 15 6.3
ADME — 1 assays, 1 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 1 1 6.1

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine